Within-Subject test of blinded study medication: Clinical Trials

2 trials of Within-Subject test of blinded study medication, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Within-Subject test of blinded study medication: new trials by email Literature Review of Within-Subject test of blinded study medication trials Research Report on Within-Subject test of blinded study medication

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Sleep Disruption on Drug Response
Within-Subject test of blinded study medication - Low Back Pain, Recurrent, Healthy
Phase 2CompletedJohns Hopkins University1092019-10-072026-10-21
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
Within-subject test of blinded study medication - Opioid Sensitivity, Individual Difference
Phase 2CompletedJohns Hopkins University1002015-04-012025-02-27

Conditions studied

Low Back Pain (1)  ·  Opioid-Related Disorders (1)

Sponsors

Johns Hopkins University (2)

Countries

United States (2)

Top investigators

Kelly E Dunn, Ph.D., MBA (1)  ·  Michael T. Smith, PhD (1)

Results publications

PMID 38221808

NIH funding

R01DA035246 (1), R01DA048206 (1)